Frank D. Verbraak

7.9k citations

131 papers · 4.8k indexed · 1 hit paper · h-index 32

Ophthalmology top 0.1%
Radiology, Nuclear Medicine and Imaging top 0.2%
Molecular Biology top 10%
Biomedical Engineering top 5%
Neurology top 2%

Co-authors: Reinier O. Schlingemann Michael D. Abràmoff Mirjam E. J. van Velthoven Hille W. van Dijk Pauline H. B. Kok Milan Sonka J. Hans DeVries Mona K. Garvin
Topics: Retinal Diseases and Treatments (62 papers)Retinal Imaging and Analysis (55 papers)Glaucoma and retinal disorders (38 papers)
Cited by: Ophthalmology Radiology, Nuclear Medicine and Imaging Health Informatics
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Frank D. Verbraak

126 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus

2016 492 citations Hille W. van Dijk, Pauline H. B. Kok et al. profile →

Peers

Countries citing papers authored by Frank D. Verbraak

Since Specialization

Citations

This map shows the geographic impact of Frank D. Verbraak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank D. Verbraak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank D. Verbraak more than expected).

Fields of papers citing papers by Frank D. Verbraak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank D. Verbraak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank D. Verbraak. The network helps show where Frank D. Verbraak may publish in the future.

Co-authorship network of co-authors of Frank D. Verbraak

This figure shows the co-authorship network connecting the top 25 collaborators of Frank D. Verbraak. A scholar is included among the top collaborators of Frank D. Verbraak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank D. Verbraak. Frank D. Verbraak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF 2025 ·Ophthalmology and Therapy ·(unknown),(unknown),(unknown),Frank D. Verbraak,Daniel Barthelmes,Mark C. Gillies,(unknown),Caroline C. W. Klaver	0
2	Longitudinal Assessment of Retinal Microvasculature in Preclinical Alzheimer's Disease 2024 ·Investigative Ophthalmology & Visual Science ·(unknown),Ruth M. A. van Nispen,Anouk den Braber,Elsmarieke van de Giessen,Jacoba A. van de Kreeke,H. Stevie Tan,Pieter Jelle Visser,(unknown),Frank D. Verbraak	2
3	TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration 2023 ·Acta Neuropathologica ·Anke A. Dijkstra,Tjado H. J. Morrema,(unknown),Priya Gami‐Patel,Frank D. Verbraak,Johannes F. de Boer,Femke H. Bouwman,Yolande A.L. Pijnenburg,Jurre den Haan,Annemieke J.M. Rozemüller,Jeroen J.M. Hoozemans	5
4	α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies 2023 ·npj Parkinson s Disease ·(unknown),Tjado H. J. Morrema,Jurre den Haan,(unknown),Jos W. R. Twisk,Johannes F. de Boer,Philip Scheltens,Femke H. Bouwman,Frank D. Verbraak,Annemieke J.M. Rozemüller,Jeroen J.M. Hoozemans	18
5	Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review 2023 ·Cancers ·(unknown),Tanja Alderliesten,Frank D. Verbraak,C. Rasch	8
6	High Prevalence of Previously Undiagnosed Axial Spondyloarthritis in Patients Referred With Anterior Uveitis and Chronic Back Pain: The SpEYE Study 2022 ·The Journal of Rheumatology ·(unknown),Frank D. Verbraak,(unknown),Jenny V Ongkosuwito,Maarten Boers,Hongyu Tan,Irene E. van der Horst‐Bruinsma	6
7	Translation and content validity of the Dutch Impact of Vision Impairment questionnaire assessed by Three-Step Test-Interviewing 2021 ·Journal of Patient-Reported Outcomes ·(unknown),A.J. van der Ham,Caroline B. Terwee,Frank D. Verbraak,Ger H. M. B. van Rens,Ruth M. A. van Nispen	11
8	Trustworthy AI: Closing the gap between development and integration of AI systems in ophthalmic practice 2021 ·Progress in Retinal and Eye Research ·Cristina González-Gonzalo,Eric F. Thee,Caroline C. W. Klaver,Aaron Lee,Reinier O. Schlingemann,Adnan Tufail,Frank D. Verbraak,Clara I. Sá‎nchez	55
9	High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long‐term follow‐up 2020 ·Acta Ophthalmologica ·Marilette Stehouwer,Reinier O. Schlingemann,Frank D. Verbraak	13
10	Use in clinical practice of an automated screening method of diabetic retinopathy that can be derived using a diagnostic artificial intelligence system 2020 ·Archivos de la Sociedad Española de Oftalmología (English Edition) ·Cristina Peris‐Martínez,(unknown),Warren Clarida,Ryan Amelon,(unknown),Amparo Návea,(unknown),Rosa Dolz‐Marco,(unknown),Frank D. Verbraak,Amber A. van der Heijden	2
11	The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW 2020 ·RMD Open ·Irene van der Horst‐Bruinsma,(unknown),Frank D. Verbraak,Timo Räth,James T. Rosenbaum,(unknown),Bengt Hoepken,(unknown),(unknown),Lars Bauer,Martín Rudwaleit	22
12	Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME) 2020 ·Ophthalmology Retina ·(unknown),(unknown),Frank D. Verbraak,(unknown),Johanna M. M. Hooymans,Leonoor I. Los,Aeilko H. Zwinderman,Tünde Pető,Carel B. Hoyng,Remko van Leeuwen,Johannes R. Vingerling,Annette C. Moll,Janneke J.C. van Lith-Verhoeven,Marcel G. W. Dijkgraaf,Reinier O. Schlingemann	11
13	Retinal layer thickness in preclinical Alzheimer's disease 2019 ·Acta Ophthalmologica ·Jacoba A. van de Kreeke,(unknown),Jurre den Haan,Elles Konijnenberg,Jori Tomassen,Anouk den Braber,Mara ten Kate,Lyduine E. Collij,Maqsood Yaqub,Bart van Berckel,Adriaan A. Lammertsma,Dorret I. Boomsma,H. Stevie Tan,Frank D. Verbraak,Pieter Jelle Visser	41
14	Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study) 2015 ·BMC Ophthalmology ·(unknown),Greet Dijkman,J. M. M. Hooymans,Frank D. Verbraak,Carel B. Hoyng,Marcel G. W. Dijkgraaf,Remko van Leeuwen,Johannes R. Vingerling,Annette C. Moll,Reinier O. Schlingemann	14
15	Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative age-related macular degeneration. BRAMD 2014 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),Johanna M. M. Hooymans,Frank D. Verbraak,Marcel G. W. Dijkgraaf,Tünde Pető,Johannes R. Vingerling,Carel B. Hoyng,Reinier O. Schlingemann	4
16	Antivascular Endothelial Growth Factors for Inflammatory Chorioretinal Disorders 2010 ·Developments in ophthalmology ·Maurízio Battaglia Parodi,Pierluigi Iacono,Frank D. Verbraak,Francesco Bandello	16
17	Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy 2010 ·Vision Research ·Hille W. van Dijk,Frank D. Verbraak,Marilette Stehouwer,Pauline H. B. Kok,Mona K. Garvin,Milan Sonka,J. Hans DeVries,Reinier O. Schlingemann,Michael D. Abràmoff	112
18	Preliminary OCT Findings: Macular Thickness in Patients With Diabetes Mellitus Type 2, With or Without Minimal Diabetic Retinopathy 2007 ·Investigative Ophthalmology & Visual Science ·Hille W. van Dijk,Pauline H. B. Kok,Mirjam E. J. van Velthoven,(unknown),R.O. Schlingemann,(unknown),(unknown),Frank D. Verbraak	2
19	Histological correlation of en–face OCT scans using a porcine retina. 2004 ·Investigative Ophthalmology & Visual Science ·(unknown),B. Willekens,Frank D. Verbraak,Koen Vos,Marc D. de Smet	3
20	Congenital glaucoma in a child with partial lq duplication and 9p deletion 1992 ·Ophthalmic Paediatrics and Genetics ·Frank D. Verbraak,Katalin Pogány,(unknown),Cornelia M. Mooy,H. F. de France,Raoul C.M. Hennekam,E. M. Bleeker‐Wagemakers	11

About Frank D. Verbraak

Frank D. Verbraak is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Virology, having authored 131 papers that have together received 4.8k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (62 papers), Retinal Imaging and Analysis (55 papers) and Glaucoma and retinal disorders (38 papers). The work is most often cited by research in Ophthalmology (3.5k citations), Radiology, Nuclear Medicine and Imaging (2.7k citations) and Health Informatics (66 citations). Frank D. Verbraak has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Reinier O. Schlingemann, Michael D. Abràmoff, Mirjam E. J. van Velthoven, Hille W. van Dijk, Pauline H. B. Kok, Milan Sonka, J. Hans DeVries, Mona K. Garvin, Femke H. Bouwman and Jurre den Haan. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact